Robeco Institutional Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Robeco Institutional Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,694	Closed	-$311K	–	934
2024 Q2	$311K	Hold	3,694	–	–	﹤0.01%	869
2024 Q1	$270K	Hold	3,694	–	–	﹤0.01%	891
2023 Q4	$264K	Buy	3,694 +132	+4%	+$7.79K	﹤0.01%	894
2023 Q3	$213K	Sell	3,562 -2,139	-38%	-$141K	﹤0.01%	919
2023 Q2	$411K	Buy	5,701 +2,139	+60%	+$160K	﹤0.01%	876
2023 Q1	$262K	Hold	3,562	–	–	﹤0.01%	915
2022 Q4	$238K	Buy	+3,562	New	+$232K	﹤0.01%	908

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Robeco Institutional Asset Management's LGND Position: Q3 2024 in Review

Robeco Institutional Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2024, closing a stake of 3,694 shares — an estimated $311K sold.

Robeco Institutional Asset Management first reported a position in LGND in Q4 2022 and held it in 7 quarters. The position peaked at $411K in Q2 2023. 243 funds tracked by Wall St. Rank hold LGND as of Q3 2024.

Robeco Institutional Asset Management reported no remaining Ligand Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Robeco Institutional Asset Management sold 3,694 Ligand Pharmaceuticals shares in Q3 2024, an estimated $311K.
Robeco Institutional Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2022 and held it in 7 quarters.
Robeco Institutional Asset Management's Ligand Pharmaceuticals position peaked at $411K in Q2 2023.
243 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2024, filed 29 Oct 2024.